The use of recombinant TIMP-3 has been shown to inhibit cartilage degradation both in vitro [86] and in vivo [87], confirming TIMP-3 chondroprotective activity under osteoarthritis conditions. The gene discussed is TIMP3; the disease is osteoarthritis.